Book a Meeting

Anti-CD23 Antibody, Highly Galactosylated (BioBet-GA-231ZP)

Cat#: BioBet-GA-231ZP
Target: CD23
Isotype: IgG1, κ
Host: Chimeric (primate/human)
Species Reactivity: Human

Description The Highly Galactosylated Anti-CD23 (Gomiliximab), a biobetter antibody contains with a high level of galactosylation.

Antibody Indication Allergic asthma

Classification Therapeutic antibody; biobetter

Cooperation Seeking Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD23 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.

Official Name CD23

Alternative Names Lumiliximab; 357613-86-6; IDEC-152; P5E8; gomiliximab; FCER2; Fc fragment of IgE, low affinity II, receptor for (CD23); CD23A, Fc fragment of IgE, low affinity II, receptor for (CD23A), FCE2; low affinity immunoglobulin epsilon Fc receptor; CD23; CLEC4J; BLAST-2;

Gene ID 2208

UniProt ID P06734

Cellular Localization Plasma membrane, Extracellular region or secreted

Genecards 3612

Involvement in Disease Its related pathways are Signaling by GPCR and Hematopoietic cell lineage.

Related Pathways Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B-cells (it is a B-cell-specific antigen).

Field of research N- and O-glycosylated. The secreted form sCD23 is produced by ADAM10-mediated ectodomain shedding.

Biologic Classification Protein Based Therapies
Monoclonal antibody (mAb)

Antibody Isotype IgG1, κ

Antibody Clone Gomiliximab

Description Recombinant monoclonal antibody to CD23. Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23). The drug is a chimeric antibody from Macaca irus and Homo sapiens.

Antibody Indication Allergic asthma

Allergic asthma

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2026 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas